Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series : World's leading Event Organizer

Back

Peter Mikuš

Peter Mikuš

Comenius University in Bratislava, Slovakia

Title: Determination of Drugs for Inflammatory Bowel Disease Treatment in Pharmaceuticals by Capillary Electrophoresis Hyphenated with Tandem Mass Spectrometry

Biography

Biography: Peter Mikuš

Abstract

A capillary electrophoresis (CE) method hyphenated with tandem mass spectrometry (triple quadrupole, QqQ MS) was developed for the simultaneous determination of six selected drugs used in Crohn’s disease treatment, namely azathioprine, 6-thioguanine, 6-mercaptopurine, mesalazine, prednisone and allopurinol. A 10 mM ammonium acetate adjusted at pH 9 by 3% ammonium hydroxide and including a 5% methanol addition was used as an optimum background electrolyte (BGE). The optimum BGE provided both the baseline electrophoretic separation of the drugs and highly compatible connection of CE to the electro spray ionization (ESI) interface. The optimized working conditions were favorable for the selective and sensitive QqQ MS detection of the separated compounds according to their mass-to-charge (m/z) ratios. The proposed method was validated in terms of precision (RSDs for the repeatability of migration times and peak areas of the analyzed drugs were less than 1.66% and 6.06%, respectively), linearity (determination coefficient ranged in the interval of 0.9987 - 0.9995), limits of quantitation (sub mg.mL-1 levels) and accuracy (mean recoveries of all the analytes in pharmaceutical matrix ranged in the interval of 98.23 - 101.2%). The CE-ESI-QqQ MS method is fast, simple, selective, precise, accurate, and was successfully applied to a highly reliable determination of the targeted drugs (for the treatment of inflammatory bowel disease, IBD) in commercial pharmaceuticals (tablet dosage forms). This work was supported by the projects VEGA 1/0873/15, KEGA 022UK-4/2015, APVV-15-0585 and carried out in the Toxicological and Antidoping Center at the Faculty of Pharmacy Comenius University in Bratislava.